Tag: Novartis
Swiss competition watchdog probes Novartis over patent use
The Swiss competition commission (COMCO) has opened an investigation of Novartis over possible unlawful use of a patent to reduce competitive pressure, the Swiss...
Haleon exclusive: Cross-selling creates more loyal customers
Haleon senior executive Bas Vorsteveld extols community pharmacists and explains how the profession can help the world’s biggest standalone consumer healthcare business deliver better...
Novartis drug combo shows promise in childhood brain cancer
An oral drug combination by Novartis showed promise in treating a subgroup of patients suffering from a common childhood brain cancer in a trial.
In...
NHS announces new treatment for sickle cell, seals deal with Novartis
For the first time in two decades, a new therapy with life-saving benefits will be made available on the NHS to treat patients with...
Novartis scraps sale of £805m assets including Covid-19 hopeful to Aurobindo
Novartis AG on Thursday  (2) scrapped the $1 billion (£0.81bn) sale of US generic pill and skin drug assets to India's Aurobindo Pharma Ltd as...
Novartis 2019 profits dip;Â Pfizer reports 4Q loss
Swiss pharmaceuticals giant Novartis on Wednesday reported a drop in net profit in 2019 -- a year marked by large-scale restructuring -- but saw...